NOW ENROLLING PHASE 3
[wpml_language_selector_widget]
The AMPLITUDE clinical research study is a Phase 2/3 adaptive study aiming to improve the knowledge of chronic kidney disease and potentially create better treatment options for future generations.
You can review the key eligibility criteria on the
‘Who can take part?’ page. If you know someone who may meet the eligibility criteria, we’d love to hear from you.
AMPLITUDE_HCP Study Website_v5.1_08Apr2024_en-UK
© 2024. All Rights Reserved.
